Tfh/Tfr细胞免疫平衡在血液恶性肿瘤中的研究进展
作者:
作者单位:

新疆医科大学第一附属医院 血液病中心(新疆维吾尔自治区血液病研究所), 新疆 乌鲁木齐 830054

通讯作者:

曲建华,E-mail:jhuaqu@163.com;Tel:13199855506

中图分类号:

R733

基金项目:

国家自然科学基金(No:82160034);新疆维吾尔自治区天山创新团队项目(No:2022D14008)


Research progress on Tfh/Tfr cell immune balance in hematologic malignancies
Author:
Affiliation:

The First Affiliated Hospital of Xinjiang Medical University (Institute of Hematology of Xinjiang Uygur Autonomous region) Urumqi, Xinjiang 830054, China

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [36]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    滤泡辅助性T细胞(Tfh)和滤泡调节性T细胞(Tfr)是新发现的具有相互拮抗作用的CD4+T细胞亚群。在淋巴结生发中心发挥功能和体液免疫形成过程中,Tfh细胞辅助浆细胞的抗体生成,而Tfr细胞具有抑制Tfh细胞和B细胞功能。Tfh/Tfr细胞免疫平衡对维持生发中心的形成、诱导B细胞成熟及抗体的产生等具有十分重要的意义。Tfh/Tfr细胞平衡与自身免疫疾病、实体肿瘤及部分血液系统疾病的进展密切相关,而其在血液恶性肿瘤中的作用尚不清楚。该文就Tfh/Tfr细胞的免疫平衡紊乱在血液恶性肿瘤中的最新研究进展进行综述,为恶性血液肿瘤的发病机制和免疫治疗指明新的方向。

    Abstract:

    Follicular helper T cells (Tfh) and follicular regulatory T cells (Tfr) are newly discovered CD4+ T cell subsets with opposite effects. In the process of germinal center and humoral immunity, Tfh cells assist in the production of antibodies, while Tfr cells inhibit the function of Tfh cells and B cells. The immune balance of Tfh/Tfr cells plays an important role in the formation of germinal center, the proliferation and differentiation of B cells and the production of antibodies. Tfh/Tfr cell balance is closely related to autoimmune diseases, solid tumors and some hematological diseases, but its role in malignant hematological tumors is not clear. This paper reviews the latest research progress of Tfh/Tfr cell immune balance in malignant hematological tumors, which points out a new direction for the pathogenesis and immunotherapy of malignant hematological tumors.

    参考文献
    [1] CENERENTI M, SAILLARD M, ROMERO P, et al. The era of cytotoxic CD4 T cells[J]. Front Immunol, 2022, 13: 867189.
    [2] CLEMENT R L, HANSON B L, SAGE P T. Tfh-mediated and Tfr-suppressed antigen-driven IgG and IgE assays[J]. Methods Mol Biol, 2022, 2380: 175-185.
    [3] QI J J, LIU C, BAI Z R, et al. T follicular helper cells and T follicular regulatory cells in autoimmune diseases[J]. Front Immunol, 2023, 14: 1178792.
    [4] RUBINSTEIN A, KUDRYAVTSEV I, MALKOVA A, et al. Sarcoidosis-related autoimmune inflammation in COVID-19 convalescent patients[J]. Front Med (Lausanne), 2023, 10: 1271198.
    [5] GUTIéRREZ-MELO N, BAUMJOHANN D. T follicular helper cells in cancer[J]. Trends Cancer, 2023, 9(4): 309-325.
    [6] SCHAERLI P, WILLIMANN K, LANG A B, et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function[J]. J Exp Med, 2000, 192(11): 1553-1562.
    [7] BREITFELD D, OHL L, KREMMER E, et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production[J]. J Exp Med, 2000, 192(11): 1545-1552.
    [8] CROTTY S. T follicular helper cell biology: a decade of discovery and diseases[J]. Immunity, 2019, 50(5): 1132-1148.
    [9] LONG Y, XIA C S, ZENG X Y, et al. Altered phenotypes of colonic and peripheral blood follicular helper and follicular cytotoxic T cells in mice with DSS-induced colitis[J]. J Inflamm Res, 2023, 16: 2879-2892.
    [10] XIA Y, SANDOR K, PAI J A, et al. BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4+ T cell responses to persistent antigen[J]. Immunity, 2022, 55(7): 1200-1215.e6.
    [11] HOLLERN D P, XU N, THENNAVAN A, et al. B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer[J]. Cell, 2019, 179(5): 1191-1206.e21.
    [12] HE J, TSAI L M, LEONG Y A, et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5+ CD4+ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure[J]. Immunity, 2013, 39(4): 770-781.
    [13] CHUNG Y, TANAKA S, CHU F L, et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions[J]. Nat Med, 2011, 17(8): 983-988.
    [14] DING T T, SU R, WU R H, et al. Frontiers of autoantibodies in autoimmune disorders: crosstalk between Tfh/Tfr and regulatory B cells[J]. Front Immunol, 2021, 12: 641013.
    [15] WING J B, TEKGü? M, SAKAGUCHI S. Control of germinal center responses by T-follicular regulatory cells[J]. Front Immunol, 2018, 9: 1910.
    [16] B?NELT P, W?HNER M, MINNICH M, et al. Precocious expression of Blimp1 in B cells causes autoimmune disease with increased self-reactive plasma cells[J]. EMBO J, 2019, 38(2): e100010.
    [17] JANDL C, LIU S M, CA?ETE P F, et al. IL-21 restricts T follicular regulatory T cell proliferation through Bcl-6 mediated inhibition of responsiveness to IL-2[J]. Nat Commun, 2017, 8: 14647.
    [18] OESTREICH K J, MOHN S E, WEINMANN A S. Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile[J]. Nat Immunol, 2012, 13(4): 405-411.
    [19] OLATUNDE A C, HALE J S, LAMB T J. Cytokine-skewed Tfh cells: functional consequences for B cell help[J]. Trends Immunol, 2021, 42(6): 536-550.
    [20] BETZLER A C, USHMOROV A, BRUNNER C. The transcriptional program during germinal center reaction - a close view at GC B cells, Tfh cells and Tfr cells[J]. Front Immunol, 2023, 14: 1125503.
    [21] FONSECA V R, RIBEIRO F, GRACA L. T follicular regulatory (Tfr) cells: dissecting the complexity of Tfr-cell compartments[J]. Immunol Rev, 2019, 288(1): 112-127.
    [22] NIAN Y Q, XIONG Z L, ZHAN P P, et al. IL-21 receptor blockade shifts the follicular T cell balance and reduces de novo donor-specific antibody generation[J]. Front Immunol, 2021, 12: 661580.
    [23] SAYGIN C, CARRAWAY H E. Current and emerging strategies for management of myelodysplastic syndromes[J]. Blood Rev, 2021, 48: 100791.
    [24] XIAO N, HE X, NIU H Y, et al. Increased circulating CD4+CXCR5+ cells and IgG4 levels in patients with myelodysplastic syndrome with autoimmune diseases[J]. J Immunol Res, 2021, 2021: 4302515.
    [25] 刘卉, 曹慧琴, 赵建强. 骨髓增生异常综合征患者外周血循环Tfh细胞变化及与B细胞功能异常的关系[J]. 中国实验血液学杂志, 2019, 27(4): 1196-1200.
    [26] CHA Z S, QIAN G F, ZANG Y, et al. Circulating CXCR5+CD4+ T cells assist in the survival and growth of primary diffuse large B cell lymphoma cells through interleukin 10 pathway[J]. Exp Cell Res, 2017, 350(1): 154-160.
    [27] ZHOU D M, XU Y X, ZHANG L Y, et al. The role of follicular T helper cells in patients with malignant lymphoid disease[J]. Hematology, 2017, 22(7): 412-418.
    [28] 郑静, 张祝, 陈永红, 等. Tfh/Tfr细胞失衡在B细胞淋巴瘤患者中的临床意义[J]. 中国实验血液学杂志, 2021, 29(5): 1510-1516.
    [29] SHAH U A, MAILANKODY S. Emerging immunotherapies in multiple myeloma[J]. BMJ, 2020, 370: m3176.
    [30] 马银娟, 杨柯, 杨夏影, 等. 初诊多发性骨髓瘤患者T细胞亚群和骨髓瘤细胞中PD-1、PD-L1及PD-L2的表达与意义[J]. 肿瘤防治研究, 2022, 49(1): 40-45.
    [31] 李秀钰, 胡绍雯, 朱惠芳. 白血病干细胞在急性髓系白血病治疗中的研究进展[J]. 中国现代医学杂志, 2023, 33(21): 49-57.
    [32] GUO Z X, CHEN Z P, XU Y R, et al. The association of circulating T follicular helper cells and regulatory cells with acute myeloid leukemia patients[J]. Acta Haematol, 2020, 143(1): 19-25.
    [33] DAVER N, ALOTAIBI A S, BüCKLEIN V, et al. T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments[J]. Leukemia, 2021, 35(7): 1843-1863.
    [34] VACA A M, IOANNOU N, SIVINA M, et al. Activation and expansion of T-follicular helper cells in chronic lymphocytic leukemia nurselike cell co-cultures[J]. Leukemia, 2022, 36(5): 1324-1335.
    [35] LE SAOS-PATRINOS C, LOIZON S, ZOUINE A, et al. Elevated levels of circulatory follicular T helper cells in chronic lymphocytic leukemia contribute to B cell expansion[J]. J Leukoc Biol, 2023, 113(3): 305-314.
    [36] de WEERDT I, HOFLAND T, de BOER R, et al. Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment[J]. Blood Adv, 2019, 3(17): 2642-2652.
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

张冉冉,张瑞,曲建华. Tfh/Tfr细胞免疫平衡在血液恶性肿瘤中的研究进展[J].中国现代医学杂志,2024,34(13):57-62

复制
分享
文章指标
  • 点击次数:41
  • 下载次数: 9
  • HTML阅读次数: 6
  • 引用次数: 0
历史
  • 收稿日期:2024-01-04
  • 在线发布日期: 2024-12-19
文章二维码